The Chinese medical system is moving from a planned economy to a market economy through implementing health reforms. The authors examine empirical data on China's health system from the past 10 years about the organization, financing, and equity. The data show high medical inflation rates, low percent of GDP spent on healthcare, limited relative supply of the more sophisticated tertiary centers, and increased out-of-pocket outlays. Based on linear coefficient analysis of health expenditure and utilization trends, the authors contend that the reforms need to incorporate regulatory measures that assure insurance coverage through the, reorganization of health services, delivery and financing.Pharmacology & PharmacySCI(E)3ARTICLE4341-3...
Since the economic reform in 1978, China’s health system moved from a commune-based system to a mark...
China's transition into a market economy has exerted some influence on the health sector in terms of...
<div><p>Background</p><p>High drug costs due to supplier-induced demand (SID) obstruct healthcare ac...
This paper provides an overview of the medical care system in the People\u27s Republic of China, and...
Since 1978, China has experienced a series of economic reforms, transitioning from a centrally plann...
Background: Pharmaceutical expenditure has grown by 16% per annum in China, enhanced by incentives f...
Pharmaceutical policy reform is currently one of the primary areas of health reform in China. The na...
Under the influence of national economic reform and development, China has changed the way that it f...
Despite government’s efforts in curbing prices, the health care cost in China remains high in compar...
High drug costs due to supplier-induced demand (SID) obstruct healthcare accessibility in China. Dru...
Daemmrich China’s healthcare system is experiencing significant growth from expanded government-back...
China's transition into a market economy has exerted some influence on the health sector in terms of...
China has exploded onto the world economy over the past few decades and is undergoing rapid transfor...
Following China’s recent economic growth and healthcare reform, medical services quickly merged into...
China experienced both economic and epistemological transitions within the past few decades, greatly...
Since the economic reform in 1978, China’s health system moved from a commune-based system to a mark...
China's transition into a market economy has exerted some influence on the health sector in terms of...
<div><p>Background</p><p>High drug costs due to supplier-induced demand (SID) obstruct healthcare ac...
This paper provides an overview of the medical care system in the People\u27s Republic of China, and...
Since 1978, China has experienced a series of economic reforms, transitioning from a centrally plann...
Background: Pharmaceutical expenditure has grown by 16% per annum in China, enhanced by incentives f...
Pharmaceutical policy reform is currently one of the primary areas of health reform in China. The na...
Under the influence of national economic reform and development, China has changed the way that it f...
Despite government’s efforts in curbing prices, the health care cost in China remains high in compar...
High drug costs due to supplier-induced demand (SID) obstruct healthcare accessibility in China. Dru...
Daemmrich China’s healthcare system is experiencing significant growth from expanded government-back...
China's transition into a market economy has exerted some influence on the health sector in terms of...
China has exploded onto the world economy over the past few decades and is undergoing rapid transfor...
Following China’s recent economic growth and healthcare reform, medical services quickly merged into...
China experienced both economic and epistemological transitions within the past few decades, greatly...
Since the economic reform in 1978, China’s health system moved from a commune-based system to a mark...
China's transition into a market economy has exerted some influence on the health sector in terms of...
<div><p>Background</p><p>High drug costs due to supplier-induced demand (SID) obstruct healthcare ac...